期刊文献+

风湿性心脏病继发三尖瓣关闭不全患者血清BNP、sST2蛋白水平的变化 被引量:5

Serum levels of brain natriuretic peptide and soluble ST2 in patients with tricuspid regurgitation secondary to rheumatic left heart valve disease
下载PDF
导出
摘要 目的观察风湿性心脏病继发不同程度三尖瓣关闭不全患者血清B型脑钠肽(B-type natriuretic peptide)和可溶性ST2蛋白(sST2)水平,探讨血清BNP、sST2蛋白与继发性三尖瓣关闭不全程度的相关性及意义。方法选取2014年3-5月在我院心血管外科单纯行二尖瓣置换术,伴或不伴三尖瓣手术的患者80例,其中男性20例,女性60例,中位年龄50(18-73)岁,按超声心动图测定的三尖瓣返流面积分为四组:①返流面积<2.0 cm^2为无或局限性返流组(A组),②2.0 cm^2≤返流面积<5.0 cm^2为轻度返流组(B组),③5.0 cm^2≤返流面积<10.0 cm^2为中度返流组(C组),④返流面积≥10.0 cm^2为重度返流组(D组)。用酶联免疫吸附法检测四组患者血清BNP及sST2蛋白水平,比较不同程度三尖瓣返流患者之间血清BNP及sST2蛋白水平的差异。结果C组血清BNP水平为(422.52±376.62)pg/mL,D组为(436.90±290.40)pg/mL,较A组(142.71±83.71)pg/mL明显升高,差异具有统计学意义(P〈0.01),但C、D组间差异无统计学意义(P〉0.05),B组为(210.62±181.83)pg/mL,与A组比较差异无统计学意义(P〉0.05)。C组血清sST2蛋白水平为(74.90±57.51)ng/L,A、B、D组分别为(35.25±23.33)、(48.76±32.83)、(56.87±34.46)ng/L,C组较A、B、D组明显升高,差异有统计学意义(P〈0.05),A、B、D三组组间差异无统计学意义(P〉0.05)。血清BNP水平与三尖瓣返流面积(r=0.54,P〈0.01)、左房径(r=0.28,P=0.01)、右房径(r=0.40,P〈0.01)、右室径(r=0.32,P〈0.01)呈正相关,血清sST2蛋白水平与三尖瓣返流面积(r=0.35,P〈0.01)、右房径(r=0.32,P〈0.01)呈正相关。结论继发性三尖瓣中重度返流患者血清BNP及sST2蛋白水平明显高于三尖瓣无或局限性返流患者,且二者水平三尖瓣返流面积、右房径、右室径具有显著相关性。 Objective To detect the serum levels of brain natriuretic peptide (BNP) and soluble ST2 (sST2) in the patients with tricuspid regurgitation secondary to rheumatic heart disease and estimate the correlation of the BNP and sST2 levels with the severity of secondary tricuspid regurgitation. Methods A total of 80 patients with rheumatic heart disease undergoing mitral valve replacement with or without tricuspid surgery in our center from March to May 2014 were enrolled in this study. They were 20 males and 60 males, at a median age of 50 (ranging from 18 o 73 years old). Based on the regurgitation area measured by echocardiography, they were divided into 4 groups (n=20), that is, local regurgitation group (regurgitation area 〈2.0 cm^2, group A), mild regurgitation group (2.0 cm^2 ≤area〈5.0 cm^2, group B), moderate regurgitation group (5.0 cm^2 area〈10.0 cm^2, group C), and severe regurgitation group (area≥10.0 cm^2, group D). The serum levels of BNP and sST2 were measured by ELISA, and the differences were compared among the 4 groups. Results Compared with group A (142.71±83.71 pg/mL), the serum level of BNP was significantly increased in groups C and D (422.52±376.62 and 436.90±290.40 pg/mL, P〈0.01), but no statistical difference was seen between the latter 2 groups (P〉0.05) and between group B (210.62±181.83 pg/mL) and group A. The serum level of sST2 was the highest in group C (74.90±57.51 ng/L) when compared with the other 3 groups (P〈0.05), and was 35.25±23.33, 48.76±32.83 and 56.87±34.46 ng/L respectively in the groups A, B and D, without significant difference among them (P〉0.05). Correlation analysis showed that the serum level of BNP had positive correlation with tricuspid regurgitation area (r=0.54,P〈0.01), left atrium diameter (r=0.28, P〈0.01), right atrium diameter (r=0.40,P〈0.01) and right ventricular diameter(r=0.32, P〈0.01), meanwhile that of sST2 was positively correlated with tricuspid regurgitation (r=0.35, P〈0.01) and right atrium diameter were (r=0.32, P〈0.01). Conclusion Serum BNP and sST2 levels are significantly higher in the patients with moderate and severe tricuspid regurgitation than those with local tricuspid regurgitation, and are positively correlated with the regurgitation area, right atrium diameter and right ventricular diameter.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2015年第21期2186-2189,共4页 Journal of Third Military Medical University
基金 国家科技支撑计划(2011BAI11B19)~~
关键词 风湿性心脏病 继发性三尖瓣关闭不全 sST2蛋白 B型脑钠肽 rheumatic heart disease secondary tricuspid soluble ST2 brain natriuretic peptide
  • 相关文献

参考文献16

  • 1Boyaci A, Gokce V, Topaloglu S, et al. Outcome of significant functional tricuspid regurgitation late after mitral valve replacement for predominant rheumatic mitral stenosis[J]. Angiology, 2007, 58(3): 336-342.
  • 2Januzzi J L, Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management[J]. Circulation, 2013, 127(4): 500-507.
  • 3Vanderheyden M, Vrints C, Verstreken S, et al. B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications[J]. Biomark Med, 2010, 4(2): 315-320.
  • 4Heart Failure Society of America, Lindenfeld J, Albert N M, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline.[J]. J Card Fail, 2010, 16(6): e1-e194.
  • 5Troughton R W, Lewis L K, Yandle T G, et al. B-type natriuretic peptides: looking to the future[J]. Ann Med, 2011, 43(3): 188-197.
  • 6张堃,张新超.ST2与心肌梗死和心力衰竭的关系[J].中国心血管杂志,2012,17(4):314-316. 被引量:15
  • 7Miller A M, Liew F Y. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease[J]. Pharmacol Ther, 2011, 131(2): 179-186.
  • 8Dieplinger B, Egger M, Koehler W, et al. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit- The Linz Intensive Care Unit (LICU) study[J]. Clin Chim Acta, 2012, 413(5/6): 587-593.
  • 9Di-Somma S, Magrini L, Pittoni V, et al. In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study[J]. Crit Care, 2010, 14(3): R116.
  • 10Casaclang-Verzosa G, Gersh B J, Tsang T S. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation[J]. J Am Coll Cardiol, 2008, 51(1): 1-11.

二级参考文献21

  • 1Sims JE. IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol, 2002, 14: 117-122.
  • 2Schmitz J,Owyang A, Oldham E, et al. IL-33, an interleukin-1- like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity, 2005, 23: 479-490.
  • 3Sanada S, Hakuno D, Higgins LJ, et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest, 2007, 117: 1538-1549.
  • 4Meisel C, Bonhagen K, L-hning M, et al. Regulation and function of T1/ST2 expression on CD4 + T ceils: induction of type 2 cytokine production by T1/ST2 cross-linking. J Immunol, 2001, 166: 3143-3150.
  • 5Dinarello CA. An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity. 2005 ; 23:461-462.
  • 6Ali S, Huber M, Kollewe C, et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A, 2007, 104: 18660- 18665.
  • 7Kakkar R,Lee RT. The IL-33/ST2 pathway: therapeutic target and Novel biomarker. Nat Rev Drug Discov, 2008, 7 : 827-840.
  • 8Weinberg EO, Shimpo M, de Keulenaer GW, et al. Expression and Regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation, 2002, 106 : 2961-2966.
  • 9Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation, 2004, 109: 2186-2190.
  • 10Weir RA, Miller AM, Murphy GE, et al. Serum soluble ST2 : a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coil Cardiol, 2010, 55 : 243 -250.

共引文献14

同被引文献55

  • 1蒋春英,王蕊,李旭东,吴强,韩冰.单纯收缩期高血压患者血浆B型钠尿肽水平与左心室肥厚、舒张功能变化的关系[J].中国动脉硬化杂志,2015,23(1):73-77. 被引量:12
  • 2Karthikeyan G,Ananthakrishnan R,Devasenapathy N,et al.Transient,subclinical atrial fibrillation and risk of systemic embolism in patients with rheumatic mitral stenosis in sinus rhythm[J].Am J Cardiol,2014,114(6):869-874.
  • 3Tomai F,Gaspardone A,Versaci F,et al.Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis[J].Int J Cardiol,2014,177(3):881-885.
  • 4Sergeeva I,Christoffels V M.Regulation of expression of atrial and brain natriuretic peptide,biomarkers for heart development and disease[J].Biochim Biophys Acta,2013,1832(12):2403-2413.
  • 5Cantinotti M,Emdin M,Clerico A.B-type natriuretic peptide assay for complex congenital heart diseases:clinical relevance versus methodological issues[J].J Am Coll Cardiol,2013,61(19):2022-2023.
  • 6de Almeida F R,Alencar M C N,de Souza A C,et al.Ventilatory inefficiency in patients with rheumatic mitral stenosis[J].Int J Cardiol,2015,193:36-38.
  • 7Vaneet Kumar K,Sanjeev A,Prem A,et al.B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia:a marker of severity?[J].Pediatr Pulmonol,2015,50(5):1106-1111.
  • 8Baysal A,Sasmazel A,Yildirim A,et al.The predictive value of plasma B-type natriuretic peptide levels on outcome in children with pulmonary hypertension undergoing congenital heart surgery[J].Rev Bras Anestesiol,2014,64(5):531-531.
  • 9Kenyu S,Toshie S,Fumitaka T,et al.Cardiovascular risk stratification with plasma B-type natriuretic peptide levels in a community-based hypertensive cohort[J].Am J Cardiol,2014,113(4):682-686.
  • 10路娟,李红梅,张在女.超声诊断风湿性心脏病乳头肌、腱索病损1例[J].现代中西医结合杂志,2008,17(15):2378-2378. 被引量:1

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部